ACHE and myasthenia gravis: In pharmacology, AChE is also a therapeutic target for other neurological and muscular disorders, including myasthenia gravis, organophosphate poisoning, and Parkinson’s disease Recent studies have identified antiviral drugs, such as tilorone, that exhibit inhibitory activity against AChE, opening new possibilities for drug repurposing [4].